Lyra Therapeutics Inc

NASDAQ:LYRA

5.19

-0.20 (-3.71%)

5:37:50 PM EDT: $5.44 +0.25 (+4.82%)

Market Cap (Intraday)	310.07M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.35 Million
Adjusted EPS	-$0.26

See more estimates

10-Day MA	$5.36
50-Day MA	$5.50
200-Day MA	$4.25

See more pivots

Lyra Therapeutics Inc Stock, NASDAQ:LYRA

480 Arsenal Way, Watertown, Massachusetts 02472

United States of America

Phone: +1.617.393.4600

Number of Employees: 88

http://www.lyratherapeutics.com

Description

Lyra Therapeutics, Inc. is a clinical-stage therapeutics company. It develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases. The firms proprietary XTreo deliver medicines. The company was founded by Carmichael S. Roberts, George M. Whitesides, and Robert S. Langer in November 2005 and is headquartered in Watertown, MA.